Dopamine versus norepinephrine: Is one better?

Minerva Anestesiologica

Volumn 75, Issue 5, 2009, Pages 333-337

  Vincent, J Louis ^a   Biston, P ^b   Devriendt, J ^c   Brasseur, A ^a   De Backer, D ^a  

^a ERASME HOSPITAL   (Belgium)

^b Centre Hospitalier Universitaire de Charleroi   (Belgium)

^c BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adrenergic; Beta; Dopamine; Norepinephrine; Receptors; Shock

Indexed keywords

DOPAMINE; NORADRENALIN; PLACEBO; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HYPOPHYSIS HORMONE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG PROTEIN BINDING; GASTROINTESTINAL TRACT; HUMAN; HYPOTENSION; KIDNEY; LOW DRUG DOSE; NONHUMAN; RESPIRATORY SYSTEM; SEPTIC SHOCK; TACHYCARDIA; ADENOHYPOPHYSIS; ADRENERGIC SYSTEM; ANIMAL; BREATHING; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART OUTPUT; ISCHEMIA; KIDNEY CIRCULATION; LIVER CIRCULATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SECRETION; SHOCK; SPLANCHNIC BLOOD FLOW;

ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIAC OUTPUT; DOPAMINE; DOUBLE-BLIND METHOD; HUMANS; ISCHEMIA; KIDNEY; LIVER CIRCULATION; NOREPINEPHRINE; PITUITARY GLAND, ANTERIOR; PITUITARY HORMONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL CIRCULATION; RESPIRATION; SHOCK; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; VASOMOTOR SYSTEM;

EID: 67650152646     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 2004;98:461-468
2. Olsen NV, Olsen MH, Bonde J, Kanstrup IL, Plum I, Strandgaard S et al. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study. Br J Clin Pharmacol 1997;43:509-520 (Pubitemid 27224011)
3. Gordon IL, Wesley R, Wong DH, Ingegno MD, Spivak B, Wilson SE. Effect of dopamine on renal blood flow and cardiac output. Arch Surg 1995;130:864-868
4. Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998;26:260-265 (Pubitemid 28082686)
5. Lee MR. Dopamine and the kidney: ten years on. Clin Sci (Lond) 1993;84:357-375
6. Dick M, Dasta JF, Choban PS, Sinha R, Flancbaum L. Serum aldosterone concentrations and urine output in oliguric intensive care unit patients receiving low-dose dopamine. Ann Pharmacother 1994;28:837-841 (Pubitemid 24262643)
7. Seri I, Kone BC, Gullans SR, Aperia A, Brenner BM, Ballermann BJ. Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na(+)-K(+)-ATPase. Am J Physiol 1990;258:F52-F60.
8. Hubbard PC, Henderson IW. Renal dopamine and the tubular handling of sodium. J Mol Endocrinol 1995;14:139-155
9. Power DA, Duggan J, Brady HR. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Clin Exp Pharmacol Physiol (Suppl) 1999;26:S23-S28. (Pubitemid 29283596)
10. Benmalek F, Behforouz N, Benoist JF, Lafay M, Mimoz O, Samii K et al. Renal effects of low-dose dopamine during vasopressor therapy for posttraumatic intracranial hypertension. Intensive Care Med 1999;25:399-405. (Pubitemid 29192474)
11. Ichai C, Soubielle J, Carles M, Giunti C, Grimaud D. Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: a single-blind randomized study. Crit Care Med 2000;28:921-928 (Pubitemid 30262056)
12. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994;120:744-747 (Pubitemid 24125294)
13. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB et al. Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993;21:56-61.
14. Graves TA, Cioffi WG, Vaughan GM, Pratt L, Heironimus JD, McManus WF et al. The renal effects of low-dose dopamine in thermally injured patients. J Trauma 1993;35:97-102.
15. Girbes AR, Lieverse AG, Smit AJ, van Veldhuisen DJ, Zwaveling JH, Meijer S et al. Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth 1996;77:753-757 (Pubitemid 27023311)
16. Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G et al. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothorac Anesth 1990;4:469-473 (Pubitemid 20232617)
17. Elkayam U, Ng TM, Hatamizadeh P, Janmohamed M, Mehra A. Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation 2008;117:200-205
18. Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985;13:492-496 (Pubitemid 15063837)
19. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996;22:213-219 (Pubitemid 126423676)
20. Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 1998;24:564-568 (Pubitemid 28344757)
21. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000;356:2139-2143 (Pubitemid 32047951)
22. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002;28:877-883
23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
24. Moore FA. The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 1999;178:449-453 (Pubitemid 30058289)
25. Schmidt H, Secchi A, Wellmann R, Bohrer H, Bach A, Martin E. Effect of low-dose dopamine on intestinal villus microcirculation during normotensive endotoxaemia in rats. Br J Anaesth 1996;76:707-712 (Pubitemid 26129548)
26. Giraud GD, MacCannell KL. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 1984;230:214-220 (Pubitemid 14097680)
27. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-1357 (Pubitemid 24323617)
28. Segal JM, Phang PT, Walley KR. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992;73:1159-1164
29. Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K. The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997;23:31-37 (Pubitemid 27067893)
30. Olson D, Pohlman A, Hall JB. Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance. Am J Respir Crit Care Med 1996;154:1664-1670 (Pubitemid 26424932)
31. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC. Increasing splanchnic blood flow in the critically III. Chest 1995;108:1648-1654
32. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003;31:1659-1667
33. Fidone SJ, Gonzalez C, Yoshizaki K. Putative neurotransmitters in the carotid body: the case for dopamine. Fed Proc 1980; 39:2636-2640 (Pubitemid 10019536)
34. Zapata P, Zuazo A. Reversal of respiratory responses to dopamine after dopamine antagonists. Respir Physiol 1982;47:239-255 (Pubitemid 12187897)
35. Olson LG, Hensley MJ, Saunders NA. Ventilatory responsiveness to hypercapnic hypoxia during dopamine infusion in humans. Am Rev Respir Dis 1982;126:783-787 (Pubitemid 13241056)
36. Ciarka A, Rimacchi R, Vincent JL, Velez-Roa S, Dumonceaux M, Leeman M et al. Effects of low-dose dopamine on ventilation in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 2004; 34:508-512 (Pubitemid 39049856)
37. Saldias FJ, Comellas AP, Pesce L, Lecuona E, Sznajder JI. Dopamine increases lung liquid clearance during mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 2002;283:L136-L143. (Pubitemid 34764550)
38. Aubier M, Murciano D, Menu Y, Boczkowski J, Mal H, Pariente R. Dopamine effects on diaphragmatic strength during acute respiratory failure in chronic obstructive pulmonary disease. Ann Intern Med 1989;110:17-23. (Pubitemid 19032789)
39. Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34.
40. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-1590 (Pubitemid 26313763)
41. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994;41:731-737
42. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab 1994;79:1141-1146 (Pubitemid 24342262)
43. Devins SS, Miller A, Herndon BL, O'Toole L, Reisz G. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992;20:1644-1649
44. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993;103:1826-1831
45. Marin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990;18:282-285 (Pubitemid 20086856)
46. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993;19:151-154 (Pubitemid 23193707)
47. Ledoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000;28:2729-2732 (Pubitemid 30676515)
48. Hannemann L, Reinhart K, Grenzer O, Meier-Hellmann A, Bredle DL. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995;23:1962-1970 (Pubitemid 26002764)
49. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000;28:2758-2765 (Pubitemid 30676520)
50. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006;34:589-597 (Pubitemid 43308242)
51. Povoa PR, Carneiro AH, Ribeiro OS, Pereira AC. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Crit Care Med 2009;37:736-740